4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000008
Director sold 13,464 shares at $123.68 ($1,665,228)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
JEFFS ROGER · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-02 | Sale : show line 1 in the form 10b5-1 | −13,464 | $123.68 | $1,665,228 | 57,510 | D |
| Open-market sales · 13,464 sh · avg $123.68 · $1,665,228 | ||||||
Loading xslF345X05/ownership.xml…